RxDoctor Payments Data

Laura Jones, DO

Family Medicine · Bedford, TXNPI 1801158134

Payments from drug & device makers

$243in general payments, 2019–2025

Across 16 payments — averaging $15.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$37
  • Boehringer Ingelheim$34
  • GSK$31
  • AstraZeneca$27
  • Bristol Myers Squibb$21
  • Abbott$17
  • plus $75 from 5 others

What the payments were for

  • Food & beverage$243100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$243 in reported general payments places this provider in the 35th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$92,615
Medicare patients
264
Services billed
3,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$109,299
MounjaroTirzepatide43$57,182
EliquisApixaban47$50,628
TrulicityDulaglutide26$39,518
JardianceEmpagliflozin32$34,327
JanuviaSitagliptin Phosphate14$22,874
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$16,624
XareltoRivaroxaban12$14,253
FarxigaDapagliflozin Propanediol12$12,696
MyrbetriqMirabegron22$11,753
Breo ElliptaFluticasone/Vilanterol12$6,547
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$5,325
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$5,174
SavellaMilnacipran Hcl11$5,153
Gabapentin223$4,513

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$50,62847 claims
Boehringer IngelheimJardiance$34$34,32732 claims
GSKTrelegy Ellipta, Breo Ellipta$31$23,17123 claims
MerckJanuvia$16$22,87414 claims
AstraZenecaFarxiga$27$12,69612 claims
AbbVieSavella, Synthroid$15$6,96031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Bedford

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →